This product is a recombinant human antibody that recognizes IFNG. The antibody was purified by affinity chromatography. It can be used in ICC, WB, Block, ELISA, IHC.
Figure 1 AF2 neutralization of IFNγ-mediated induction of MHC class II molecule expression on Hs294T cells.
Histograms depict the level of HLA±DR expression (as determined by indirect immunofluorescence using L243) on Hs294T cells that have been incubated in the absence of IFNγ (dotted line), or in the presence of 125 pM IFNγ with (solid line) or without (dashed line) 1 nM AF2.
Thakur, A. B., & Landolfi, N. F. (1999). A potent neutralizing monoclonal antibody can discriminate amongst IFNγ from various primates with greater specificity than can the human IFNγ receptor complex. Molecular immunology, 36(15-16), 1107-1115.
Figure 2 Titration of AF2 neutralization of IFNg activity.
(A) Titration of AF2 neutralization of IFNg activity on Hs294T cells. Graph represents the median fluorescent intensity of HLA±DR expression (as determined by indirect immunofluorescence using L243) on Hs294T cells incubated with IFNg and increasing concentrations of AF2. Dashed line indicates fluorescence intensity of Hs294T cells incubated in the absence of IFNg. (B) Titration of ability of AF2 to inhibit 125I-IFNg binding to Daudi cells. Graph depicts amount of bound 125I-IFNg in the presence of increasing concentrations of AF2. The 125I-IFNg cpm bound in the presence of a great excess (650 nM) of an isotype matched control antibody was 3862±420; 125I-IFNg cpm bound in the presence of 100× (150 nM) concentration of unlabeled IFNg was 510±138.
Thakur, A. B., & Landolfi, N. F. (1999). A potent neutralizing monoclonal antibody can discriminate amongst IFNγ from various primates with greater specificity than can the human IFNγ receptor complex. Molecular immunology, 36(15-16), 1107-1115.
Figure 3 AF2 does not bind to rhesus IFNγ.
Graph indicates the level of inhibition of AF2 binding to plate bound human IFNγ by IFNγ containing supernatants from human and rhesus PBMCs.
Thakur, A. B., & Landolfi, N. F. (1999). A potent neutralizing monoclonal antibody can discriminate amongst IFNγ from various primates with greater specificity than can the human IFNγ receptor complex. Molecular immunology, 36(15-16), 1107-1115.
Figure 4 Neutralization of primate IFNγ by AF2.
Graph displays the percent of IFNγ neutralization (as indicated by inhibition of HLA-DR expression induction). Hs294T cells were incubated with IFNγ containing supernatant from the indicated primate along with 10 nM AF2. The level of HLA-DR expression in terms of median channel fluorescence in the absence of AF2 was 33 for human, 17 for chimpanzee, 33 for gorilla, 38 for orangutan, 28 for gibbon, 21 for baboon, 31 for rhesus, 15 for marmoset.
Thakur, A. B., & Landolfi, N. F. (1999). A potent neutralizing monoclonal antibody can discriminate amongst IFNγ from various primates with greater specificity than can the human IFNγ receptor complex. Molecular immunology, 36(15-16), 1107-1115.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
NABL-090 | Recombinant Anti-human IFNG VHH Single Domain Antibody | WB, ELISA, IHC, FC, FuncS | Llama VHH |
TAB-140CT | Anti-Human IFN-γ Therapeutic Single Domain Antibody (TAB-140CT) | ELISA | Single domain antibody |
TAB-141CT | Anti-Human IFN-γ Therapeutic Single Domain Antibody (TAB-141CT) | ELISA | Single domain antibody |
TAB-142CT | Anti-Human IFN-γ Therapeutic Single Domain Antibody (TAB-142CT) | ELISA | Single domain antibody |
TAB-143CT | Anti-Human IFN-γ Therapeutic Single Domain Antibody (TAB-143CT) | ELISA | Single domain antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-041 | Anti-Human IFNG Recombinant Antibody (Fontolizumab) | IP, IF, FuncS, FC, Neut, ELISA, IHC | IgG1 |
PABX-113 | Recombinant Human Anti-IFN-gamma Antibody (HuZAF) | WB, ELISA, FuncS | IgG |
PABX-113-F (E) | Recombinant Human Anti-IFN-gamma Antibody Fab Fragment (HuZAF) | WB, ELISA, FuncS | Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
PFBW-079 | Human Anti-IFNG Recombinant Antibody (clone AF-2); Fab Fragment | Neut, ELISA | Humanized Fab |
FAMAB-0162-CN-F(E) | Human Anti-IFNG Recombinant Antibody (clone 41ms4G); Fab Fragment | ELISA | Human Fab |
FAMAB-0163-CN-F(E) | Human Anti-IFNG Recombinant Antibody (clone 57-5); Fab Fragment | ELISA | Human Fab |
FAMAB-0164-CN-F(E) | Human Anti-IFNG Recombinant Antibody (clone 36-4); Fab Fragment | ELISA | Human Fab |
FAMAB-0165-CN-F(E) | Human Anti-IFNG Recombinant Antibody (clone 44ms4); Fab Fragment | ELISA | Human Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-0289MC | Recombinant Anti-Canine IFN-gamma Antibody. | WB, ELISA |
CAT | Product Name | Application | Type |
---|---|---|---|
PABX-112 | Recombinant Human Anti-IFN Antibody (ScFv01) | Neut, FuncS | IgG |
PABX-112-S (P) | Recombinant Human Anti-IFN Antibody scFv Fragment (ScFv01) | Neut, FuncS | scFv |
PABX-113-S (P) | Recombinant Human Anti-IFN-gamma Antibody scFv Fragment (HuZAF) | WB, ELISA, FuncS | scFv |
PABX-112-F (E) | Recombinant Human Anti-IFN Antibody Fab Fragment (ScFv01) | Neut, FuncS | Fab |
TAB-423CQ | Anti-Human IFNG Recombinant Antibody (Emapalumab) | ELISA, IHC, FC, IP, IF, FuncS | IgG1, λ1 |
CAT | Product Name | Application | Type |
---|---|---|---|
NEUT-1002CQ | Mouse Anti-IFNG Recombinant Antibody (clone CBL253) | Inhib, IHC, IP | Mouse IgG1 |
NEUT-1008CQ | Mouse Anti-IFNG Recombinant Antibody (clone B133.5) | Block | Mouse IgG1 |
NEUT-1013CQ | Mouse Anti-IFNG Recombinant Antibody (clone B-B1) | Block, FC | Mouse IgG1 |
NEUT-1014CQ | Mouse Anti-IFNG Recombinant Antibody (clone D9D10) | Block, FC, ELISA, WB | Mouse IgG1 |
NEUT-1033CQ | Mouse Anti-IFNG Recombinant Antibody (clone SN-6) | ELISA, Block | Mouse IgG1, κ |
CAT | Product Name | Application | Type |
---|---|---|---|
NEUT-1018CQ | Mouse Anti-IFNG Recombinant Antibody (clone NIB42) | ELISA, Neut, IP, RIA | Mouse IgG1 |
NEUT-1019CQ | Mouse Anti-Ifng Recombinant Antibody (clone CBL981) | ELISA, Neut, WB | Mouse IgG1 |
NEUT-1020CQ | Rat Anti-Ifng Recombinant Antibody (clone mAb0854) | IHC-Fr, Neut | Rat IgG1 |
NEUT-1021CQ | Rat Anti-Ifng Recombinant Antibody (clone R4-6A2) | ELISA, IHC, IHC-Fr, Neut, WB | Rat IgG1 |
NEUT-1022CQ | Rat Anti-Ifng Recombinant Antibody (clone XMG1.2) | Neut | Rat IgG1, κ |
CAT | Product Name | Application | Type |
---|---|---|---|
MOR-4228 | Rabbit Anti-IFNG Recombinant Antibody (clone SI307DS) | FC | Rabbit IgG |
MOR-4229 | Rabbit Anti-IFNG Recombinant Antibody (clone SI308DS) | FC | Rabbit IgG |
MOR-4230 | Rabbit Anti-IFNG Recombinant Antibody (clone SI309DS) | FC | Rabbit IgG |
MOR-4600 | Rabbit Anti-IFNG Recombinant Antibody (clone TH113DS) | WB | Rabbit IgG |
MOR-4601 | Rabbit Anti-IFNG Recombinant Antibody (clone TH114DS) | WB | Rabbit IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
EPAF-0882LC | Mouse Anti-IFNG Recombinant Antibody (clone MIF3009) | ELISA | Mouse IgG1 |
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-083CQ | Mouse Anti-IFNG Recombinant Antibody (clone YC117) | FC | Mouse IgG2b |
MOB-084CQ | Mouse Anti-IFNG Recombinant Antibody (clone YC116) | ELISA, FC | Mouse IgG1 |
MOB-085CQ | Rabbit Anti-Guinea Pig IFNG Polyclonal Antibody | ICC, IHC, WB, IP | Rabbit IgG |
MOB-083LC | Mouse Anti-IFNG Recombinant Antibody (clone YC114) | FC, IP, WB | Mouse IgG |
FAMAB-0162-CN | Human Anti-IFNG Recombinant Antibody (clone 41ms4G) | ELISA | Human IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
FAMAB-0176-YC-S(P) | Mouse Anti-IFNG Recombinant Antibody (clone D9DlO); scFv Fragment | ELISA, WB | Mouse scFv |
FAMAB-0180-CN-S(P) | Human Anti-IFNG Recombinant Antibody (clone 59-5); scFv Fragment | ELISA | Human scFv |
HPAB-S0067-YC-S(P) | Human Anti-IFNG Recombinant Antibody (clone chAF2); scFv Fragment | ELISA, Neut | Mouse scFv |
HPAB-S0068-YC-S(P) | Human Anti-IFNG Recombinant Antibody (clone Haf25); scFv Fragment | ELISA, Neut | Humanized scFv |
HPAB-S0069-YC-S(P) | Human Anti-IFNG Recombinant Antibody (clone HuXAF); scFv Fragment | ELISA, Neut | Humanized scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
AFC-TAB-041 | Afuco™ Anti-IFNG ADCC Recombinant Antibody (Fontolizumab), ADCC Enhanced | IP, IF, FuncS, FC, Neut, ELISA | ADCC enhanced antibody |
AFC-TAB-423CQ | Afuco™ Anti-IFNG ADCC Recombinant Antibody (Emapalumab), ADCC Enhanced | ELISA, IHC, FC, IP, IF, FuncS | ADCC enhanced antibody |
There are currently no Customer reviews or questions for FAMAB-1197CQ. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.